Market Place
Sourcing Support
Cobra Biologics, CombiGene Ready to Start GMP Production of Epilepsy Drug
25 Jun 2021 //
CONTRACTPHARMA
Cobra Produces Master Cell Banks for CombiGene’s Gene Therapy
18 Aug 2020 //
CONTRACTPHARMA
Cobra Biologics Delivers Plasmids for CombiGene`s Epilepsy Candidate
13 Jul 2020 //
CONTRACTPHARMA
Cobra Biologics to Manufacture AstraZeneca’s COVID-19 Vaccine Candidate
17 Jun 2020 //
PHARMTECH
Cobra Biologics signs supply agreement with AZ for manufacture of COVID-19
16 Jun 2020 //
PRNEWSWIRE
Cobra Biologics Completes Key CombiGene Milestone
02 Apr 2020 //
CONTRACT PHARMA
Cognate BioServices closes Series B and completes acquisition of Cobra Biologics
27 Jan 2020 //
BUSINESSWIRE
CombiGene, Cobra Biologics Sign Production Pact
16 Oct 2019 //
CONTRACT PHARMA
Cobra Biologics & Symbiosis £1.9m Inovate from Innovate UK
01 Feb 2018 //
PRESS RELEASE
Cobra Biologics Awarded $3.4M by Innovate UK
30 Jan 2018 //
CONTRACT PHARMA
Cobra awarded £2.6m from Innovate UK for expansion
24 Jan 2018 //
PHARMA TIMES
Cobra Biologics to pump $19M into its U.K. and Swedish production facilities
18 Apr 2017 //
FIERCE PHARMA
Cobra Biologics Receives Biomanufacturing Research Funding
03 Mar 2015 //
DCAT CONNECT
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.